Folding intermediates are involved in genetic diseases?
- 6 February 1995
- journal article
- Published by Wiley in FEBS Letters
- Vol. 359 (1) , 6-8
- https://doi.org/10.1016/0014-5793(95)00004-s
Abstract
Recent experimental data show that some human genetic diseases are due to mutations in proteins which influence their trafficking and lead to retaining of proteins in the endoplasmic reticulum or their unproper processing. In this paper a hypothesis is proposed that these mutations are connected with an incomplete protein folding, blocking it at the stage of the kinetic molten globule or even earlier. If so, the specific drugs against these diseases may be ligands and other factors which facilitate the correct protein folding.Keywords
This publication has 29 references indexed in Scilit:
- Conformation of GroEL-bound α-lactalbumin probed by mass spectrometryNature, 1994
- High-Resolution Structure of the Oligomerization Domain of p53 by Multidimensional NMRScience, 1994
- Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic MutationsScience, 1994
- The chaperonin GroEL does not recognize apo-α-lactalbumin in the molten globule stateNature Structural & Molecular Biology, 1994
- Structural and energetic consequences of disruptive mutations in a protein coreBiochemistry, 1992
- Chaperonin-mediated protein folding at the surface of groEL through a 'molten globule'-like intermediateNature, 1991
- The ‘molten globule’ state is involved in the translocation of proteins across membranes?FEBS Letters, 1988
- Single amino acid mutations block a late step in the folding of β-lactamase from Staphylococcus aureusJournal of Molecular Biology, 1985
- Temperature-sensitive mutants blocked in the folding or subunit assembly of the bacteriophage P22 tail spike proteinJournal of Molecular Biology, 1981
- Temperature-sensitive mutants blocked in the folding or subunit assembly of the bacteriophage P22 tail spike proteinJournal of Molecular Biology, 1981